9 completed. 9 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 9 |
| Phase 2 | 4 | Completed 4 |
Follow Hypopigmentation: new trials by email Literature Review of Hypopigmentation trials Research Report on Hypopigmentation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo 0.03% tacrolimus twice daily was applied on group A patients with uvb phototherapy thrice daily - Vitiligo | Phase 1 | Completed | Combined Military Hospital Abbottabad | 60 | 2021-05-01 | 2022-10-17 |
| Effects of Combination Therapy With Camouflage in the Repigmentation of Vitiligo CapulinTM, topical applications and NB-UVB - Vitiligo | Phase 1 | Completed | Peking University People's Hospital | 30 | 2019-08-01 | 2020-07-07 |
| Nitisinone for Type 1B Oculocutaneous Albinism Nitisinone - Albinism, Vision Loss | Phase 1 / Phase 2 | Completed | National Eye Institute (NEI) | 5 | 2013-04-16 | 2019-02-26 |
| Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV) Afamelanotide, Narrow-Band UVB Light Treatment - Vitiligo | Phase 1 | Completed | Clinuvel Pharmaceuticals Limited | 56 | 2011-06-01 | 2013-03-22 |
| Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo autologous (cellular therapy) - Vitiligo | Phase 1 / Phase 2 | Completed | Centre Hospitalier Universitaire de Nice | 23 | 2011-05-01 | 2014-02-03 |
| Melanocyte Transplantation for Patients With Stable Vitiligo. Laser CO2 - Stable Vitiligo | Phase 1 / Phase 2 | Completed | Clinica Universidad de Navarra, Universidad de Navarra | 30 | 2010-12-01 | 2013-10-14 |
| Effect of Procedural Variables on Outcome of Surgical Treatment of Vitiligo Melanocyte-keratinocyte suspension - Vitiligo | Phase 1 | Completed | Cairo University | 40 | 2010-01-01 | 2015-07-29 |
| Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents Ginkgo biloba - Vitiligo Vulgaris | Phase 1 | Completed | University of Toronto | 12 | 2009-05-01 | 2010-07-08 |
| A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia Imatinib (Gleevec) - Leukemia | Phase 1 / Phase 2 | Completed | University Health Network, Toronto | 35 | 2004-07-01 | 2015-06-24 |
Vitiligo (7) · Albinism (1) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Piebaldism (1) · Vision Disorders (1)
Pigmentation Disorders (9) · Skin Diseases (9) · Skin and Connective Tissue Diseases (9) · Amino Acid Metabolism, Inborn Errors (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Nutritional and Metabolic Diseases (2) · Skin Diseases, Genetic (2) · Albinism (1) · Eye Diseases (1) · Hematologic Diseases (1)
Lasers, Gas (2) · Cell- and Tissue-Based Therapy (1) · Ginkgo Extract (1) · Imatinib Mesylate (1) · afamelanotide (1) · nitisinone (1)
Cairo University (1) · Centre Hospitalier Universitaire de Nice (1) · Clinica Universidad de Navarra, Universidad de Navarra (1) · Clinuvel Pharmaceuticals Limited (1) · Combined Military Hospital Abbottabad (1) · National Eye Institute (NEI) (1) · Peking University People's Hospital (1) · University Health Network, Toronto (1) · University of Toronto (1)
Canada (2) · United States (2) · China (1) · France (1) · Pakistan (1) · Spain (1)
Brian P Brooks, M.D. (1) · Heather Boon, PhD (1) · Henry Lim, MD (1) · Juan Du, Doctor (1) · Orest Szczurko, ND MSc(cand) (1) · Philippe Bahadoran, PH (1)
PMID 21406109, PMID 25230094, PMID 25902042, PMID 30674731
2009 (1)